Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Nevada: The Complete Support and Litigation Guide for Patients and Families

When you underwent breast reconstruction or a cosmetic procedure in Nevada, you trusted that every material placed inside your body was specifically tested, scrutinized, and approved for that exact use. For many women in Las Vegas, Reno, Henderson, and across the Silver State, that trust has been shattered. We are now seeing a disturbing reality: many of the products used in breast surgeries—including acellular dermal matrix (ADM), bioabsorbable scaffolds like GalaFLEX, and synthetic meshes—were never actually cleared or approved by the FDA for use in the breast.

We represent women and families in Nevada who are now facing the devastating consequences of these regulatory failures. Whether you are a breast cancer survivor who underwent reconstruction at a major institution like University Medical Center (UMC) in Las Vegas or Renown Health in Reno, or you are a cosmetic surgery patient navigating complications after an “internal bra” procedure in Summerlin or Henderson, you deserve to know the truth about what was implanted in your body. At the Manginello Law Firm, PLLC, operating as Attorney911, our managing partner Ralph Manginello and associate Lupe Peña use their combined decades of experience—including Lupe’s background in insurance defense and our firm’s admission to federal court—to fight for those harmed by medical device manufacturers.

If you are experiencing pain, swelling, reconstruction failure, or have been diagnosed with BIA-ALCL or BIA-SCC, our team is ready to listen. We offer full consultations in English and Spanish (hablamos español) with no upfront costs. You can reach us 24/7 at 1-888-ATTY-911 (1-888-288-9911).

The Hidden Reality of Breast Mesh and Scaffolds in Nevada

In recent years, surgeons across Nevada have increasingly turned to biological and synthetic “scaffolds” to provide support for breast implants or tissue expanders. While these materials are often marketed as providing a more natural aesthetic or “internal bra” support, the regulatory truth is significantly more complicated.

What are ADMs and Bioabsorbable Scaffolds?

Acellular Dermal Matrix (ADM) is a biologic material derived from human or animal skin that has been processed to remove cells, leaving behind a structural collagen framework. Products like AlloDerm (Allergan/AbbVie), Strattice, FlexHD, and AlloMax (Becton Dickinson) are frequently used in Nevada reconstruction cases.

Bioabsorbable scaffolds, such as GalaFLEX and Phasix (manufactured by Becton Dickinson/Bard/Galatea), are synthetic materials made from poly-4-hydroxybutyrate (P4HB). These are designed to provide temporary support and then gradually dissolve as your own tissue takes over.

The FDA’s Explicit Warning

What many patients in Nevada do not know—and what many were never told during informed consent—is that the FDA issued a critical letter to healthcare providers on November 9, 2023. In this communication, the FDA stated verbatim: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.”

The agency went further, listing products like GalaFLEX Scaffold, GalaFLEX 3D, and Phasix Mesh, and clarifying that these devices were never cleared for breast-specific applications. When a manufacturer promotes a device for an unapproved use, it is known as “off-label promotion,” and it forms a core component of our litigation strategy against companies like Becton Dickinson and Allergan.

Why These Devices Fail: The Science of Injury

At Attorney911, we believe that understanding the pathology of your injury is the first step toward justice. Ralph Manginello and our team work with leading medical experts to examine how these scaffolds and matrices interact with human tissue, often with catastrophic results for Nevada patients.

Endotoxins and Red Breast Syndrome

Many ADM products, including FlexHD and AlloMax, have been associated with a condition known as Red Breast Syndrome (RBS). This is a non-infectious, sterile inflammatory reaction where the skin becomes bright red over the area of the implant. Peer-reviewed research, including studies by Nguyen et al. (2019), suggests this is caused by bacterial endotoxins (lipopolysaccharides) that remain on the matrix even after it has been sterilized. For a patient in Nevada, RBS can be frightening, often mimicking a severe infection and leading to unnecessary antibiotic treatments or premature explant surgery.

Predicate Creep and the 510(k) Loophole

Most of these devices reached the Nevada market through the FDA’s 510(k) clearance pathway. This pathway allows a manufacturer to sell a device if they can show it is “substantially equivalent” to a device already on the market (a predicate).

We have seen a phenomenon called “predicate creep.” For example, the GalaFLEX scaffold reached the market by claiming it was equivalent to a surgical suture. A suture is used for wound closure; a scaffold is used to support the weight of a breast implant. These are not equivalent uses, yet the 510(k) system allowed this material to enter Nevada operating rooms without a single human clinical trial for breast surgery. As Ralph Manginello often tells our clients, these companies essentially treated Nevada women as a massive, unconsented clinical trial.

Premature Failure and Chronic Pain

Bioabsorbable scaffolds like GalaFLEX are supposed to provide support for 18 to 24 months as they resorb. However, many Nevada women report that the material fails prematurely, leading to “bottoming out” or lateral displacement of the implant. Conversely, others report the material does not dissolve as advertised, leaving behind hard, palpable mesh edges that cause chronic neuropathic pain and intercostal neuralgia.

Oncological Risks: BIA-ALCL and BIA-SCC in Nevada

The most severe complications associated with breast implants and adjacent materials involve rare but aggressive cancers of the immune system and the surgical capsule.

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

BIA-ALCL is a CD30-positive, ALK-negative T-cell lymphoma. It is not breast cancer; it is a cancer of the immune system that develops in the fluid or scar tissue surrounding a textured implant. The FDA’s 2019 recall of Allergan BIOCELL textured implants was a watershed moment for Nevada patients. Research shows that textured surfaces provide a larger area for bacterial biofilm to form, which triggers a chronic inflammatory state that can lead to malignant transformation.

If you were implanted with textured devices at a clinic in the Las Vegas Valley or Northern Nevada and are experiencing late-onset seroma (fluid collection) 7 to 10 years after surgery, you must seek immediate medical evaluation.

Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC)

In September 2022, and again in March 2023, the FDA issued safety communications regarding BIA-SCC, a different type of cancer found in the capsule surrounding both textured and smooth implants. BIA-SCC is highly aggressive, with latency periods ranging from 7 to 42 years post-implantation.

The Noorchashm Record: A Whistleblower’s Warning

When we litigate these cases in the U.S. District Court for the District of Nevada or in coordinated proceedings nationally, we look at internal manufacturer records. A critical figure in this litigation is Dr. Hooman Noorchashm, a cardiothoracic surgeon and former Medical Director for Becton Dickinson.

After being terminated in 2022, Dr. Noorchashm filed a whistleblower lawsuit alleging that BD withheld critical data from the FDA. His allegations include:

• Concealing breast cancer recurrences in patients who received GalaFLEX.
• Failing to report hundreds of adverse events in the FDA’s MAUDE database.
• Engaging in aggressive off-label marketing to Nevada surgeons for procedures that had no established safety profile.

This whistleblower record provides powerful evidence for our clients. It suggests that when a manufacturer tells a Nevada doctor that a product is “safe and effective,” they may be doing so while suppressing their own contrary data.

Legal Rights and Statutes of Limitation in Nevada

Navigating a medical device lawsuit requires a deep understanding of Nevada’s specific legal framework.

Statutes of Limitation

In Nevada, the statute of limitations for personal injury and product liability is generally two years from the date of the injury (NRS 11.190). However, most device cases fall under the discovery rule. This means the clock may not start ticking until you knew, or reasonably should have known, that your injury was caused by the defective mesh or scaffold.

For many women in Nevada, the “discovery” date might be November 2023, when the FDA first explicitly stated these devices were not cleared for breast surgery. If you suspect your complications are linked to an implant, ADM, or scaffold, do not wait. Contact Ralph Manginello or Lupe Peña today to protect your right to file.

Damages You Can Recover

Through a successful lawsuit or settlement, we fight to recover:

• Past and Future Medical Expenses: This includes the cost of revision surgeries, explantation (removal), IV antibiotics for sepsis, and long-term cancer monitoring.
• Lost Wages and Earning Capacity: Many of our Nevada clients have missed months or years of work due to chronic pain and multiple surgeries.
• Pain and Suffering: The physical agony of reconstruction failure and the psychological trauma of permanent disfigurement.
• Punitive Damages: In cases where we can prove a manufacturer like Becton Dickinson or Allergan acted with malice or fraud by concealing risks, Nevada law may allow for punitive damages to punish the company.

Why Experience Matters: The Attorney911 Advantage

Not all personal injury firms are equipped to handle complex medical device litigation. At Attorney911, we differentiate ourselves through technical command and proven results.

1. Insiders on Your Side: Lupe Peña’s past experience in insurance defense gives us a unique perspective. We know how the other side thinks, how they value claims, and how they try to minimize your suffering.
2. Proven Large-Scale Litigation: Our firm is currently lead counsel in high-profile litigation seeking $10 million in damages (Bermudez v. Pi Kappa Phi, November 2025). We have the resources and the “grit” to go head-to-head with multi-billion-dollar corporations like BD and AbbVie.
3. Hablamos Español: We believe every woman in Nevada deserves access to justice, regardless of her primary language. Lupe Peña conducts full consultations in Spanish, ensuring that no detail of your story is lost in translation.
4. No Results, No Fee: We work on a contingency fee basis. This means we advance all the costs of experts, filing fees, and medical record retrieval. We only get paid if we recover money for you.

Taking Action: How to Start Your Claim in Nevada

If you have experienced complications following breast surgery in Nevada, follow these steps to preserve your legal rights:

• Request Your Full Operative Reports: You have a legal right to your medical records. Specifically, ask for the “Implant Logs” or “Device Stickers.” These contain the Unique Device Identifier (UDI), model, and lot numbers we need to identify the manufacturer.
• Preserve Evidence: If you require explant surgery, your attorney can send a “preservation letter” to the hospital in Nevada ensuring that the device is not destroyed. The device itself is critical physical evidence.
• Document Everything: Keep a journal of your symptoms, keep copies of all medical bills, and take photographs of visible complications (with the guidance of your counsel).
• Call 1-888-ATTY-911: Speak with Ralph Manginello or Lupe Peña for a free, confidential case evaluation.

Frequently Asked Questions for Nevada Patients

Is GalaFLEX “approved” for breast reconstruction?
No. According to the FDA’s November 2023 letter, GalaFLEX was cleared through the 510(k) pathway for general soft tissue reinforcement, but its safety and effectiveness in breast surgery have not been determined or approved by the FDA.

What if my surgery was years ago?
Nevada’s discovery rule may protect you. If you only recently learned that your complications were linked to the device—perhaps because of the 2023 FDA update—you may still be within the statute of limitations.

Can I sue if I have “Breast Implant Illness” (BII)?
Yes. While BII is a constellation of systemic symptoms currently being studied, many women report significant improvement after explant. We evaluate these cases based on the manufacturer’s failure to warn about potential systemic immune responses.

Who do we sue—the doctor or the manufacturer?
In most cases, the primary defendant is the manufacturer of the mesh or scaffold. While a Nevada surgeon may have used the product, the manufacturer has the primary legal duty to provide honest, accurate data about the product’s safety.

Will my case be a class action?
Most medical device cases are handled as Mass Torts or integrated into a Multidistrict Litigation (MDL). This means your case remains individual to your specific injuries, but the evidence-gathering (discovery) is coordinated across thousands of cases to maximize pressure on the defendants.

Contact Us Today for a Free Nevada Case Evaluation

You chose reconstruction to feel whole again, or augmentation to feel more confident. You did not choose to become a victim of a defective medical device. Whether you are in Clark County, Washoe County, or any rural Nevada community, we are here to help you hold these corporations accountable.

Ralph Manginello, Lupe Peña, and the entire team at Attorney911 are ready to fight for you. We provide the technical authority of a national firm with the personal attention of a dedicated local advocate.

Call us now at 1-888-ATTY-911 (1-888-288-9911) or contact us online to schedule your free, no-obligation consultation. Hablamos español. You pay nothing unless we win your case.

Disclaimer: This content is for educational and informational purposes only and does not constitute legal advice. Past results in cases like Bermudez v. Pi Kappa Phi or prior settlements do not guarantee a similar outcome in your case. An attorney-client relationship is only formed through a signed written agreement with The Manginello Law Firm, PLLC.